[Aldosterone antagonists for all patients with heart failure?].
Bauersachs
Johann
J
Medizinische Klinik I, Universitätsklinikum, Julius-Maximilians-Universität Würzburg. bauersachs_j@medizin.uni-wuerzburg.de
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D000077545:Eplerenone; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D007677:Kidney Function Tests; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D011188:Potassium / Q000097:blood; D013148:Spironolactone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016019:Survival Analysis
D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone; D011188:Potassium